GTC
CTIC

Ghost Tree Capital’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Ghost Tree Capital’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,000,000
Closed -$8.4M – 73
2023
Q1 		$8.4M Buy
2,000,000
+150,000
+8% +$779K 2.48% 12
2022
Q4 		$11.1M Sell
1,850,000
-150,000
-8% -$819K 4.75% 7
2022
Q3 		$11.6M Buy
2,000,000
+1,200,000
+150% +$7.48M 3.27% 12
2022
Q2 		$4.78M Sell
800,000
-500,000
-38% -$2.56M 2.49% 17
2022
Q1 		$6.07M Buy
1,300,000
+100,000
+8% +$298K 1.32% 17
2021
Q4 		$2.98M Sell
1,200,000
-400,000
-25% -$979K 1.07% 37
2021
Q3 		$4.72M Hold
1,600,000
– – 1.38% 27
2021
Q2 		$4M Buy
1,600,000
+850,000
+113% +$2.04M 1.1% 33
2021
Q1 		$2.18M Hold
750,000
– – 0.51% 43
2020
Q4 		$2.42M Buy
+750,000
New +$2.49M 0.54% 36

Other funds holding CTIC

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Ghost Tree Capital's CTIC Position: Q2 2023 in Review

Ghost Tree Capital sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 2,000,000 shares — an estimated $8.4M sold.

Ghost Tree Capital first reported a position in CTIC in Q4 2020 and held it in 10 quarters. The position peaked at $11.6M in Q3 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

  • Ghost Tree Capital reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
  • Ghost Tree Capital sold 2,000,000 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $8.4M.
  • Ghost Tree Capital first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q4 2020 and held it in 10 quarters.
  • Ghost Tree Capital's CTI BioPharma Corp. (DE) Common Stock position peaked at $11.6M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on Ghost Tree Capital's 13F filing for Q2 2023, filed 14 Aug 2023.